Your browser doesn't support javascript.
loading
Hodgkin lymphoma involving extranodal sites in head and neck: report of twenty-nine cases and review of three-hundred and fifty-seven cases.
Akhtar, Saad; Khafaga, Yassir; Edesa, Wael; Al-Mubarak, Mustafa; Rauf, M Shahzad; Maghfoor, Irfan.
Afiliação
  • Akhtar S; King Faisal Specialist Hospital and Research Center, Oncology Center, Riyadh, Kingdom of Saudi Arabia.
  • Khafaga Y; King Faisal Specialist Hospital and Research Center, Oncology Center, Riyadh, Kingdom of Saudi Arabia.
  • Edesa W; King Faisal Specialist Hospital and Research Center, Oncology Center, Riyadh, Kingdom of Saudi Arabia.
  • Al-Mubarak M; King Faisal Specialist Hospital and Research Center, Oncology Center, Riyadh, Kingdom of Saudi Arabia.
  • Rauf MS; King Faisal Specialist Hospital and Research Center, Oncology Center, Riyadh, Kingdom of Saudi Arabia.
  • Maghfoor I; King Faisal Specialist Hospital and Research Center, Oncology Center, Riyadh, Kingdom of Saudi Arabia.
Hematology ; 26(1): 103-110, 2021 Dec.
Article em En | MEDLINE | ID: mdl-33478377
ABSTRACT

INTRODUCTION:

Hodgkin lymphoma (HL) involving the Waldeyer's ring (WR) and other extranodal head and neck sites are rare. We report our experience and PubMed literature review.

METHODS:

Retrospective single institution cohort study using lymphoma data base and PubMed literature search using twenty-six various search terms.

RESULTS:

Twenty-nine patients were treated in our institution (1975-2018). MaleFemale 227, median age at diagnosis 33 years (15-64), stages I-IIIII-IV 254. Sites were nasopharynx (10), tonsil (9), parotid (5), mandible (2) and others (3). 20/29 patients received radiation therapy, 22/29 received chemotherapy. Ten years overall-survival and progression-free survival are 92% and 66% respectively. PubMed search showed 8766 citations and identified 357 patients including our patients. MaleFemale 199131, median age 45 years (5-89). Stages I-II in 286 (80%). Involvement was nasopharynx 109 (30.5%), tonsil 67 (18.8%), parotid 58 (16.2%), thyroid 45 (12.6%), adenoid 10 (2.8%), mandible 10 (2.8%) and others in 58 (16.2%). Pathology mixed cellularity 99 (27.7%), nodular sclerosis 88 (24.6%), nodular lymphocyte-predominant 56 (15.7%), lymphocyte rich 25 (7%), classical-HL-not otherwise specified 16 (4.5%) and lymphocyte depleted 7 (2%) patients. Treatment details are available for 233 patients; 165 (46%) received radiation therapy, 137 (38%) chemotherapy. Complete remission in 208 (58%), progressive disease 14 (4%), no information 135 (38%). Overall, treatment failure in 54 (15%). Thirty (8.4%) have died; 21 disease related. KM overall-survival at 5 and 10 years was 88.5% and 77.6% respectively.

CONCLUSION:

This largest report showed that HL involving extranodal head and neck sites is not very uncommon and has excellent prognosis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Extensão Extranodal / Neoplasias de Cabeça e Pescoço Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Hematology Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Extensão Extranodal / Neoplasias de Cabeça e Pescoço Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Hematology Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article